AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 67 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $20,085,026 | +1857.6% | 1,343,480 | +977.8% | 0.01% | – |
| Q3 2022 | $1,026,000 | +460.7% | 124,650 | +398.6% | 0.00% | – |
| Q1 2021 | $183,000 | +27.1% | 25,000 | 0.0% | 0.00% | – |
| Q4 2020 | $144,000 | -3.4% | 25,000 | 0.0% | 0.00% | – |
| Q3 2020 | $149,000 | +15.5% | 25,000 | 0.0% | 0.00% | – |
| Q2 2020 | $129,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $22,809,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 1,151,175 | $6,642,000 | 0.47% |
| X-Square Capital, LLC | 75,952 | $438,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 68,092 | $393,000 | 0.08% |
| WealthTrust Axiom LLC | 22,347 | $128,000 | 0.05% |
| Opaleye Management Inc. | 58,800 | $339,000 | 0.04% |
| Trexquant Investment LP | 64,838 | $374,000 | 0.04% |
| PDT Partners, LLC | 60,117 | $347,000 | 0.02% |
| PERSONAL CFO SOLUTIONS, LLC | 13,000 | $75,000 | 0.02% |
| CVI Holdings, LLC | 13,171 | $76,000 | 0.01% |